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The excitotoxicity induced by excessive activation of the glutamatergic neurotransmission pathway is
involved in several neuropathologies. In this sense, molecules that prevent the release of glutamate or
the excessive activation of its receptors can be useful in preventing the neuronal cell death observed
in these diseases. Lectins are proteins capable of reversible binding to the carbohydrates in glycoconju-
gates, and some have been used in the study and puriﬁcation of glutamate receptors. ConBr is a mannose/
glucose-binding lectin puriﬁed from Canavalia brasiliensis seeds. In the present study, we aimed to eval-
uate the neuroprotective activity of ConBr against glutamate-induced excitotoxicity. Hippocampal slices
were isolated from adult male mice and incubated for 6 h in Krebs saline/DMEM buffer alone (control), in
the presence of glutamate or glutamate plus ConBr. The phosphorylation of Akt and mitogen activated
protein kinases (MAPKs) such as ERK1/2, p38MAPK and JNK1/2/3 was evaluated with western blotting.
The results indicate that glutamate provoked a reduction in the hippocampal slice viability (25%),
diminished the phosphorylation of Akt and augmented p38MAPK and ERK1 phosphorylation. No changes
were observed in the phosphorylation of JNK1/2/3 or ERK2. Notably, ConBr, through a mechanism depen-
dent on carbohydrate interaction, prevented the reduction of cell viability and Akt phosphorylation
induced by glutamate. Furthermore, in the presence of the PI3K inhibitor LY294002, ConBr was unable
to reverse glutamate neurotoxicity. Taken together, our data suggest that the neuroprotective effect of
ConBr against glutamate neurotoxicity requires oligosaccharide interaction and is dependent on the
PI3K/Akt pathway.
 2013 Elsevier Ltd. Open access under the Elsevier OA license.1. Introduction
Sugar chains, which are present in glycoproteins, are constitu-
ents of biological membranes that can act as biosignaling mole-
cules (Dube and Bertozzi, 2005) inﬂuencing a variety of cell
signaling pathways (Greengard, 2001; Thomas and Huganir,
2004; Wong and Scott, 2004). Therefore, carbohydrates can per-
form key roles in the development, neuroplasticity and synaptic
modulation of the central nervous system (CNS) (Matthies et al.,
1999; Dube and Bertozzi, 2005; Endo, 2005). The information con-
tained in the structure of oligosaccharides conjugated to proteins
or lipids on the cell surface is recognized by a specialized group
of proteins named lectins (Sanz-Aparicio et al., 1997).de Bioquímica, Centro de
Catarina, Florianópolis, SC
8 3331 9672.
lsevier OA license.Lectins are a heterogeneous group of proteins capable of revers-
ible binding to carbohydrates and glycoconjugates and thus regu-
lating several physiological and pathological events (Dube and
Bertozzi, 2005; Liu and Rabinovich, 2005). In the CNS, synapses
are sites that are rich in carbohydrates (Rambourg and Leblond,
1967). Moreover, it has been shown that glycoproteins present in
the synaptic region are potentially involved in regulating synaptic
activity (Gurd, 1989; Wing, 1993). Nevertheless, except for galec-
tin-1, a lectin expressed in the CNS that displays galactose afﬁnity,
few lectins have been isolated and characterized concerning their
potential roles in neural tissue (Ghazarian et al., 2010; Yamane
et al., 2010).
Lectins with mannose/glucose afﬁnity obtained from plants,
such as concanavalin A (ConA), a lectin extracted from the seeds
of Canavalia ensiformis, have been employed as tools to study neu-
roplasticity (Lin and Levitan, 1991; Scherer and Udin, 1994), to iso-
late and study synaptic glycoproteins (Partin et al., 1993; Fay and
Bowie, 2006), to study neurotransmitter release (Boehm and Huck,
A.V. Jacques et al. / Neurochemistry International 62 (2013) 836–842 8371998) and to study monoamine receptors and transporters (Cedeñ-
o et al., 2005). Furthermore, it has been shown that ConA is able to
bind and modulate glutamatergic receptors (Yue et al., 1995; Fay
and Bowie, 2006).
ConBr is a lectin with an afﬁnity for mannose/glucose isolated
from the Brazilian bean C. brasiliensis. The sequence and crystallo-
graphic structure of ConBr has been deﬁned, and the amino acid
sequence displays a 99% homology with ConA (Sanz-Aparicio
et al., 1997; Cavada et al., 2001). The biological effects of ConBr
in peripheral tissues include the stimulation of histamine release
in mast cells (Lopes et al., 2005), the stimulation of nitric oxide
production in macrophages (Andrade et al., 1999) and the activa-
tion of apoptosis in lymphocytes (Barbosa et al., 2001). Despite
these actions and the structural similarity between ConBr and
ConA (Cavada et al., 2001), the biological effects of ConBr on neural
cells and its role in the CNS have not been well studied.
Our group previously demonstrated that ConBr, but not ConA,
presents an antidepressant-like action via the activation of the
monoaminergic system; this action was assessed in mice with
the forced swimming test (Barauna et al., 2006). Moreover, in a re-
cent study we showed that ConBr may act as a potential inhibitor
of N-methyl-D-aspartate (NMDA) receptor activation, possibly
counteracting the calcium inﬂux gated by this ionotropic gluta-
mate receptor. ConBr was able to block the seizures, the cell death,
the activation of the AMPA subtype of glutamate receptors and the
JNK2/3 phosphorylation induced by quinolinic acid, a synthetic
agonist of the NMDA receptor (Russi et al., 2012).
Glutamate is the major excitatory neurotransmitter in the CNS
of mammals; however, an excess of glutamate in the synaptic cleft
may be toxic to neural cells, inducing cell death as a result of the
excessive inﬂux of Ca2+ (Choi, 1987; Bonfoco et al., 1995; Meldrum,
2000; Lynch and Guttmann, 2002). Due to the NMDA receptor’s
high permeability to Ca2+ and incomplete desensitization, this
receptor is considered to be the main mediator of glutamatergic
excitotoxicity (Choi, 1992; Rothstein, 1996; Gonda, 2012). The
mechanisms of cell death in response to glutamatergic excitotoxic-
ity are unclear but are likely to involve the release of apoptotic fac-
tors, the activation of mitogen activated protein kinases (MAPKs)
(Schwarzschild et al., 1997; Yang et al., 1997; Molz et al., 2008b)
and the inhibition of the PI3K/AKT pathway (Chuang et al., 2011;
Molz et al., 2011; Sun et al., 2012).
Extracellular signal-regulated kinases (ERK1/2), c-Jun N-termi-
nal kinases (JNK1/2/3) and p38MAPK are serine-threonine kinases
and members of the MAPKs family that are modulated in response
to a variety of extracellular signals including growth factors, cyto-
kines and neurotransmitters. They are involved in the processes of
neurodevelopment and neuroplasticity because they mediate var-
ious cellular responses, such as proliferation, differentiation, syn-
aptic activity, cell survival and cell death (Chen et al., 2001; Chu
et al., 2004; Thomas and Huganir, 2004; Sweatt, 2004; Waetzig
and Herdegen, 2004; Kim and Choi, 2010). The phosphatidylinosi-
tol 3-kinase (PI3K)/Akt (or PKB) pathway can also be modulated by
growth factors and neurotransmitters, and its activation plays a
central role in the regulation of cell growth, proliferation, metabo-
lism, cell survival and neuroplasticity (Hanada et al., 2004; Brazil
et al., 2004; Van Der Heide et al., 2006).
It is noteworthy that the inhibition of p38MAPK (Molz et al.,
2008b), the knockdown of JNK3 (Yang et al., 1997; Bogoyevitch
et al., 2010) and the activation of PI3K/AKT (Piermartiri et al.,
2009; Chuang et al., 2011; Molz et al., 2011; Lee et al., 2012; Sun
et al., 2012) all result in a neuroprotective effect against glutamate
excitotoxicity. Moreover, the selective NMDA receptor antagonist
dizocilpine maleate (MK-801), promoted cell survival and in-
creased the phosphorylation of Akt.
Taking all these aspects together, the present study was de-
signed to investigate the neuroprotective capacity of ConBr in anin vitro model of glutamatergic excitotoxicity on hippocampal
slices. Moreover, we aimed to establish the putative involvement
of the MAPKs and the PI3K/Akt pathway in the neuroprotective
mechanism displayed by ConBr. Our results reinforce previous data
that indicate that the neuroprotective potential of ConBr is depen-
dent on the carbohydrate recognition domain (CRD) interaction.
Moreover, the present data show, for the ﬁrst time, that ConBr
can counteract glutamate excitotoxicity by a mechanism depen-
dent on PI3K/Akt activation.2. Materials and methods
2.1. Chemicals
The anti-phospho-ERK1/2, anti-phospho-JNK1/2/3, anti-phos-
pho-Akt and anti-total-AKT antibodies as well as the LumiGLO
chemiluminescent substrate, were purchased from Cell Signaling
(Beverly, MA, USA). The anti-phospho-p38MAPK, anti-total-p38MAPK,
anti-total-ERK1/2 and anti-total-JNK1/2 antibodies, as well as the
PI3K inhibitor LY294002, were obtained from Sigma (St. Louis,
MO, USA). The goat anti-rabbit IgG HRP (horseradish peroxidase)-
conjugated secondary antibody was obtained fromMillipore (Bille-
rica, MA, USA). The Dulbecco’s modiﬁed Eagle’s medium (DMEM)
was purchased from Gibco. Tris and b-mercaptoethanol were ob-
tained from Amresco (Solon, OH, USA). The MTT, SDS, and bis-
acrylamide were from USB (Cleveland, OH, USA). Acrylamide,
Hyperﬁlm™, and Hybond™ nitrocellulose were purchased from
GE Healthcare Life Sciences (Piscataway, NJ, USA). All of the other
reagents were of high analytical grade.
2.2. Animals
Male adult Swiss mice (approximately 50 days old and weigh-
ing between 30 and 40 g) were provided by the Universidade Fed-
eral de Santa Catarina (UFSC, Brazil) breeding colony. The mice
were housed in plastic cages with food and water available ad libi-
tum and maintained in an air-conditioned room (22 ± 1 C) on a
12 h light/dark cycle. The animals were treated, manipulated and
euthanized according to the ‘‘Principles of Laboratory Animal Care’’
(NIH publication no. 80-23, revised 1996), and the experiments
were approved by the Committee on the Ethics of Animal Experi-
ments of the Federal University of Santa Catarina (CEUA/UFSC;
www.ceua.ufsc.br; Permit Number PP00345). All efforts were
made to minimize the number of animals used and animal
suffering.
2.3. Lectin puriﬁcation
The C. brasiliensis lectin was puriﬁed by classical methods,
including precipitation with ammonium sulfate and afﬁnity chro-
matography on a Sephadex-G-50 column. The homogeneity of all
lectin preparations was monitored by SDS–PAGE, as described pre-
viously (Moreira and Cavada, 1984; Cavada et al., 2001).
2.4. Preparation of hippocampal slices
The preparation and treatment of hippocampal slices were per-
formed as previously described (Cordova et al., 2004; Molz et al.,
2008a). Brieﬂy, the animals were euthanized by decapitation, their
encephala were extracted and the hippocampi were immediately
dissected (at 4 C) in Krebs–Ringer bicarbonate buffer (KRB)
(122 mM NaCl, 3 mM KCl, 1.2 mM MgSO4, 1.3 mM CaCl2, 0.4 mM
KH2PO4, 25 mM NaHCO3 and 10 mM D-glucose). The buffer was
bubbled with a mixture of 95% O2 and 5% CO2 up to pH 7.4. Slices
of 400 lm thickness were prepared using a McIlwain tissue chop-
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slice) for 30 min at room temperature (RT). For the treatments,
the medium was replaced with a nutritive incubation medium
composed of 50% KRB, 50% Dulbecco’s modiﬁed Eagle’s medium
(DMEM), 20 mMHEPES and 100 lg/ml of gentamicin, and the sam-
ples were incubated at 37 C in a 95% O2/5% CO2 atmosphere. The
treatments were divided into four groups: control (KRB/DMEM),
glutamate, ConBr and glutamate co-administered with ConBr. In
another set of experiments, the PI3K inhibitor LY294002 (10 lM)
was added during the 30 min of pre-incubation and during the
6 h of treatment.
2.5. Cell viability
The viability of the cells in the slices was analyzed with the col-
orimetric MTT [30-(4,5-dimethylthiazol-2yl) 2,5-diphenyltetrazoli-
um bromide] reduction assay (Liu et al., 1997). After the
treatments, the medium was removed, and the slices (in tripli-
cates) were incubated with 0.5 mg/ml MTT (200 ll) in KRB. The
slices were incubated for 20 min at 37 C. The mitochondrial dehy-
drogenases in viable cells reduce the MTT to formazan crystals,Fig. 1. The neuroprotective effect of ConBr against glutamate neurotoxicity was depend
glutamate in hippocampal slices incubated for 6 h in Krebs saline/DMEM buffer alone (con
of control and values are presented as mean ± SEM of six independent experiments
concentrations of ConBr (0.1–100 lg/ml) administered alone on cell viability. (C) Shows
Krebs saline/DMEM buffer alone (control) or in the presence of glutamate 10 mM, or glu
Values are presented as mean ± SEM of six independent experiments performed in tripl
images of MTT treated hippocampal slices (using 4X objective) of control, ConBr alone, Gl
of the CRD in the neuroprotective activity of ConBr against the glutamate neurotoxicity
Thereafter, hippocampal slices were incubated for 6 h in Krebs saline/DMEM buffer alon
10 lg/mL (not blocked) or ConBr blocked with mannose. In all experiments the cell viab
considered 100%), and the values are presented as mean ± SEM of six independent ex
10 mM; $$$p < 0.001 vs. ConBr 10 lg/ml (not blocked).which were dissolved in dimethylsulfoxide (DMSO). The absor-
bance was measured spectrophotometrically using a microplate
reader (k = 540 nm). The results were expressed as a percentage
of the control (non-treated slices). In addition, the hippocampal
slices stained with the MTT formazan crystals and not solubilized
with DMSO were visualized with optical microscopy using an in-
verted NIKON eclipse T2000-U microscope.
2.6. Western blotting analysis
After the treatments, the hippocampal slices were solubilized in
sample buffer (200 mM Tris, 40 mM EDTA, 4% SDS, pH 6.8) and
immediately boiled for 5 min. After homogenization, an aliquot
was removed to determine the protein concentration with the
method described by Peterson (1977), and the concentration was
calculated using a standard curve with bovine serum albumin.
Next, sample dilution solution (1:4 vol/vol; 40% glycerol, 50 mM
Tris containing minimal bromophenol blue) and b-mercap-
toethanol (for a ﬁnal concentration of 8%) were added to each sam-
ple. The samples (60 lg of total protein/track) were
electrophoresed on 10% SDS–PAGE minigels. The proteins wereent on the carbohydrate recognition domain (CRD). (A) Shows the neurotoxicity of
trol) or in the presence of glutamate 1 or 10 mM. Data are expressed as a percentage
performed in triplicate. ⁄⁄P < 0.01 vs. control. (B) Shows the effect of increasing
the neuroprotective effect of ConBr. Hippocampal slices were incubated for 6 h in
tamate 10 mM plus ConBr at increasing concentrations (0.1, 1, 10 and 100 lg/mL).
icate. ⁄⁄⁄P < 0.001 vs. control; #P < 0.05 vs. glutamate 10 mM. (D) Illustrates optical
utamate 10 mM and Glutamate plus ConBr. Scale bar, 100 lm. (E) Evaluates the role
. In brief, ConBr was incubated with mannose (100 mM) in order to block its CRD.
e (control) or in the presence of glutamate 10 mM, or glutamate 10 mM plus ConBr
ility was assessed by MTT assay. The data are expressed as a percentage (control is
periments performed in triplicate. ⁄⁄⁄P < 0.001 vs. control; #P < 0.05 vs. glutamate
Fig. 3. Glutamate stimulates ERK1 phosphorylation but ConBr did not reverse this
effect. (A) Shows representative western blot of phosphorylated ERK1 and ERK2 and
their total content. (B) Shows quantitative analyses of ERK1 and ERK2 phosphor-
ylation. Hippocampal slices were incubated for 6 h in Krebs saline/DMEM buffer
alone (control) or in presence of ConBr 10 lg/mL, or glutamate 10 mM, or glutamate
10 mM plus ConBr 10 lg/mL. Protein analysis was performed by western blotting.
The data are expressed as percentage. The values are mean ± SEM of ﬁve
independent experiments. ⁄⁄⁄P < 0.001 and ⁄P < 0.05 vs. control group.
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blotting apparatus (TE 70 SemiPhor™ Unit, GE Healthcare Life Sci-
ences, Piscataway, NJ, USA) (1.2 mA/cm2; 1 h 30 min) as described
by Bjerrum and Heegaard (1989). The membranes were blocked
with 5% skim milk in TBS (Tris 10 mM, NaCl 150 mM, pH 7.5) for
1 h. The membranes were then incubated overnight (4 C) with pri-
mary antibodies to detect the total and phosphorylated forms of
ERK1/2, p38MAPK, JNK1/2/3 and Akt at the dilutions recommended
by the manufacturer. Subsequently, the membranes were incu-
bated for 1 h at room temperature with anti-rabbit peroxidase-
linked secondary antibody (1:4,000). All of the incubation steps
were followed by washing three times with TBS-T (Tris 10 mM,
NaCl 150 mM, Tween-20 0.1%, pH 7.5). The blots were developed
with a chemiluminescent reaction. The protein bands were quanti-
ﬁed using the Scion Image™ software (Frederick, MD, USA). The
phosphorylation level of each protein was determined by the ratio
of the OD of the phosphorylated band/OD of the total band. The
data are expressed as a percentage of the control (considered to
be 100%), and the values are presented as the mean ± SEM (Cor-
dova et al., 2012).
2.7. Statistical analysis
Statistical signiﬁcance was assessed by one-way analysis of var-
iance (ANOVA) followed by Duncan’s post-hoc test when appropri-
ate. A value of p 6 0.05 was considered to be signiﬁcant.
3. Results
The neurotoxicity of glutamate in hippocampal slices evaluated
with the MTT reduction assay is depicted in Fig. 1A. Notably, gluta-
mate exposure for 6 h caused a statistically signiﬁcant decrease in
cell viability at concentrations of 1 mM (22.27 ± 3.57%; ⁄⁄p < 0.01)
and 10 mM (26 ± 2.0%; ⁄⁄p < 0.01). ConBr (0.1–100 lg/ml) adminis-
tered alone did not change the cell viability (Fig. 1B). Based on
these results, the neuroprotective activity of ConBr lectin against
glutamatergic neurotoxicity was tested in slices incubated for 6 h
in the presence of 10 mM glutamate alone or in the presence of
increasing doses of ConBr (0.1–100 lg/ml). The results (Fig. 1C)Fig. 2. The treatments did not change the JNK1/2/3 phosphorylation. (A) Shows
representative western blot of phosphorylated JNK1 and JNK2/3 and their total
content. (B) Shows quantitative analyses of the level of JNK1 and JNK2/3
phosphorylation. Hippocampal slices were incubated for 6 h in Krebs saline/DMEM
buffer alone (control) or in presence of ConBr 10 lg/mL, or glutamate 10 mM, or
glutamate 10 mM plus ConBr 10 lg/mL. Protein analysis was performed by western
blotting. The data are expressed as percentage. The values are mean ± SEM of ﬁve
independent experiments performed in duplicate.
Fig. 4. Glutamate stimulates p38MAPK phosphorylation but ConBr did not reverse
this effect. (A) Shows representative western blot of phosphorylated p38MAPK and
and their total content. (B) Shows a quantitative analyses of p38MAPK phosphory-
lation. Hippocampal slices were incubated for 6 h in Krebs saline/DMEM buffer
alone (control) or in presence of ConBr 10 lg/mL, or glutamate 10 mM, or glutamate
10 mM plus ConBr 10 lg/mL. Protein analysis was performed by western blotting.
The data are expressed as percentage. The values are mean ± SEM of ﬁve
independent experiments. ⁄P < 0.05 vs. control group.demonstrate that glutamate (10 mM) decreased the slices’ viability
(30 ± 2.7%; ⁄⁄⁄p < 0.001) and ConBr at a concentration of 10 lg/ml
attenuated the cytotoxicity produced by glutamate (14.28 ± 1.6%;
#p < 0.05 vs. glutamate). Moreover, the glutamate neurotoxicity
and the neuroprotective effect of ConBr can be visualized in the
slices stained with MTT (Fig. 1D). In this set of experiments, the
MTT was not dissolved with DMSO, and the slices were observed
with optical microscopy. Therefore, the dehydrogenases from the
viable cells reduced MTT to formazan crystals, which were then
visualized as an intense violet color. Glutamate decreased the
staining, while the ConBr reversed this effect, conﬁrming the quan-
titative analysis shown in Fig. 1C.
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dependent on the carbohydrate recognition domain (CRD), ConBr
was incubated with mannose (100 mM) to block the lectin’s CRD.
The Fig. 1E shows that ConBr previously blocked by mannose (Con-
Br blocked) loses its protective effect against glutamate excitotox-
icity (33.28 ± 2.51%). This result indicates that the neuroprotective
effect of ConBr depends on the interaction of the lectin with glycan
chains via its CRD.
To assess the signaling pathways altered by glutamate exposure
and determine the possible mechanisms that lead to ConBr’s pro-
tective effect against glutamate excitotoxicity, the modulation of
MAPKs (ERK1/2, p38MAPK and JNK1/2/3) and PI3K/Akt were evalu-
ated 6 h after the treatment of the hippocampal slices with gluta-
mate (10 mM), ConBr (10 lg/mL) or glutamate (10 mM) co-
administered with ConBr (10 lg/mL). The results indicated that
glutamate did not alter the phosphorylation of JNK1/2/3 (Fig. 2A
and B) or ERK2 (Fig. 3). However, glutamate signiﬁcantly increasedFig. 5. PI3K/Akt pathway is involved in the neuroprotective effect of ConBr. (A)
Shows a representative western blot of phosphorylated Akt and its total content
and (B) shows quantitative analyses of the level of Akt phosphorylation. Brieﬂy,
hippocampal slices were incubated for 6 h in Krebs saline/DMEM buffer alone
(control) or in the presence of ConBr 10 lg/mL, or glutamate 10 mM, or glutamate
10 mM plus ConBr 10 lg/mL. Protein analysis was performed by western blotting.
The data are expressed as percentage of the control. The values are mean ± SEM of
ﬁve independent experiments performed in duplicate. ⁄P < 0.05 vs. control and
#P < 0.05 vs. Glutamate. (C) Shows the effect of the PI3K inhibitor, LY294002
(10 lM), on the neuroprotective effect of ConBr against the neurotoxicity of
glutamate on hippocampal slices. For this assay, hippocampal slices were incubated
for 6 h in Krebs saline/DMEM buffer alone (control) or in the presence of glutamate
10 mM, or glutamate 10 mM plus ConBr 10 lg/mL or glutamate 10 mM plus ConBr
10 lg/mL with LY294002 (10 lM). The cell viability was assessed by MTT assay.
Data are expressed as percentage of control. The values are mean ± SEM of six
independent experiments performed in triplicate. ⁄⁄⁄P < 0.001 vs. control; #P < 0.05
vs. glutamate 10 mM and $$$P < 0.001 vs. ConBr.the phosphorylation of ERK1 (26.73 ± 5.11%; ⁄⁄⁄p < 0.001; Fig. 3A
and B) and p38MAPK (35.83 ± 9.64%; ⁄p < 0.05; Fig. 4A and B). Nev-
ertheless, the co-treatment with ConBr (10 lg/mL) did not prevent
the increase in the phosphorylation of the MAPKs induced by glu-
tamate (Figs. 3 and 4). The total protein content of all of the kinases
was not modiﬁed by the treatments.
Furthermore, we evaluated the modulation of the PI3K/Akt
pathway by glutamate and/or ConBr. The results indicate that glu-
tamate (10 mM) decreased the phosphorylation of Akt in hippo-
campal slices by 24.21 ± 4.94%, ⁄p < 0.05, and the treatment with
ConBr (10 lg/mL) signiﬁcantly prevented the glutamate-induced
decrease in Akt phosphorylation (#p < 0.05; Fig. 5A and B). It is
noteworthy that the total content of Akt was not modiﬁed by
any treatment.
Based on this ﬁnding, the possible involvement of the PI3K/Akt
pathway in the neuroprotective effect of ConBr was evaluated.
Therefore, the hippocampal slices were incubated with the PI3K
inhibitor LY294002 (10 lM), and the cell viability was analyzed
after glutamate, ConBr or glutamate/ConBr treatment. Notably, in
the presence of a PI3K inhibitor (LY294002) the neuroprotective ef-
fect of ConBr was abolished (Fig. 5C). LY294002 alone (10 lM) did
not change the cell viability (Fig. 5C).4. Discussion
The present study demonstrates that ConBr protects against
glutamatergic neurotoxicity in vitro. ConBr, a mannose/glucose-
speciﬁc lectin, was able to prevent the glutamate-dependent
impairment of cell viability in hippocampal slices by a mechanism
involving the PI3K/Akt pathway. Previous studies from our group
demonstrated the beneﬁcial actions of ConBr in the function of
the CNS, including: (i) an antidepressant-like effect in the forced
swimming test (FST) by a mechanism dependent on its interaction
with the serotoninergic, noradrenergic and dopaminergic systems
(Barauna et al., 2006); and (ii) the neuroprotection against seizures
and hippocampal cell death caused by quinolinic acid (QA) injected
intracerebroventricularly (Russi et al., 2012). Therefore, the present
data reinforce the evidence that ConBr is neuroprotective.
The results clearly indicate that glutamate impairs the hippo-
campal cell viability and ConBr (10 lg/mL) reverses this effect. In
addition, our ﬁndings indicate that the interaction of ConBr with
glycans at the cell surface is a fundamental step in producing neu-
roprotection. This conclusion is supported by the fact that the
blockage of the CRD with mannose counteracted the neuroprotec-
tive effect of ConBr against glutamate excitotoxicity. Endogenous
brain lectins have been recognized as potential cell modulators
(Dube and Bertozzi, 2005; Endo, 2005; Liu and Rabinovich, 2005;
Qu et al., 2011). However, their speciﬁc functional roles in the
CNS regarding the modulation of synaptic activity and neuroplas-
ticity are not yet clear (Marschal et al., 1989; Dube and Bertozzi,
2005; Endo, 2005; Qu et al., 2011). Therefore, the present study
involving the application of a plant lectin is particularly important,
because it provides evidence concerning the interactions of glycan
chains with lectins as an additional mechanism that might be in-
volved in neuroprotection.
It is well known that excessive glutamate in the synaptic cleft
causes neuronal dysfunction and degeneration, a phenomenon
implicated in many pathological processes such as ischemia, trau-
matic brain injury, seizures and chronic neurodegenerative dis-
eases (Lau and Tymianski, 2010). The NMDA receptor, the main
receptor involved in glutamate excitotoxicity, is a glycoprotein that
displays mannose residues within the structure of the glycan
chains on the extracellular domain. Previous studies have sug-
gested that these receptors are a potential target for the man-
nose/glucose-speciﬁc lectin ConBr because the lectin blocked the
A.V. Jacques et al. / Neurochemistry International 62 (2013) 836–842 841neurotoxicity of the NMDA agonist QA (Russi et al., 2012). Like-
wise, our results obtained in an in vitro model of hippocampal glu-
tamate neurotoxicity demonstrate a clear neuroprotective effect of
ConBr and reinforce the hypothesis of an inhibitory action of ConBr
on the NMDA receptor response. Consistent with the idea of this
putative interaction of ConBr with the NMDA receptor, previous
evidence has shown that the glutamate-induced cell damage in
hippocampal slices is blocked by MK-801, a non-competitive
NMDA receptor antagonist (Molz et al., 2008b).
To investigate the alterations of cell signaling pathways by glu-
tamate and the possible involvement of these pathways in the neu-
roprotective effect attained by ConBr, the modulation of MAPKs
and PI3K/Akt was evaluated. We previously demonstrated that glu-
tamate can cause the impairment of cell viability and may induce
apoptosis in hippocampal slices by a mechanism dependent on
ionotropic receptors and p38MAPK activation (Molz et al., 2008b).
Moreover, the ERK signaling pathway may play a detrimental role
during oxidative neuronal injury, cerebral ischemia, brain trauma
and neurodegenerative diseases (Chu et al., 2004). Our results
showed that glutamatergic excitotoxicity decreased the cell viabil-
ity and resulted in the elevation of p38MAPK and ERK1 phosphory-
lation. However, ConBr did not reverse the effects on
phosphorylation, thus leading to the assumption that the route of
neuroprotection exerted by ConBr does not occur via p38MAPK or
ERK1.
Diverse growth factors and neurotransmitters can stimulate
PI3K, triggering a cascade of events that culminate with the activa-
tion of Akt via the phosphorylation of the Thr308 and Ser473 sites
(Choudhari et al., 2007; Jing et al., 2012). Akt is involved in prolif-
eration, differentiation and the protection from apoptosis that pro-
motes cell survival (Brazil and Hemmings, 2001; Kim et al., 2004).
Recently, Molz et al. (2011) showed that guanosine protects hippo-
campal slices by a mechanism that involves the PI3K/Akt/GSK3b
(Ser9) pathway and prevents glutamate-induced neurotoxicity.
Moreover, it has been shown that glutamate excitotoxicity may de-
crease PI3K/Akt activation and that neuroprotective compounds
may reverse this effect (Chuang et al., 2011; Dal-Cim et al., 2011;
Lee et al., 2012; Sun et al., 2012). Therefore, our results agree with
these previous studies and demonstrate that glutamate induces a
decrease in Akt phosphorylation and ConBr reverses this effect.
Moreover, the PI3K inhibitor LY294002 abrogated the neuroprotec-
tive effect of ConBr. These results suggest that ConBr acts via a
PI3K/Akt-dependent pathway to reverse glutamatergic
neurotoxicity.
In conclusion, our ﬁndings conﬁrm that ConBr, a mannose/glu-
cose lectin, is a protein with neuroprotective effects against gluta-
mate excitotoxicity. The mechanism involved in the action of the
lectin has not been fully elucidated but likely involves the PI3K/
Akt pathway. Because the NMDA receptor subunits (NR1 and
NR2) are glycosylated in the N-terminal extracellular domain
(Everts et al.,1997; Clark et al., 1998), it will be valuable in future
studies to address the capability of ConBr to modulate NMDA
receptors as a result of the interaction of this lectin with those oli-
gosaccharide chains.
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